On the occasion of its 40th anniversary, Transasia Bio-Medicals Ltd., India’s No. 1 Diagnostic Company, announced the launch of their international range of hematology analyzers. Backed by European R&D, the 3-Part Differential (3PD) to 5-Part Differential (5PD) fully automated hematology analyzers, reagents and controls are being introduced for the first time to Indian market.
Transasia introduced the range at a grand celebration recently at Hotel Radisson Blu,Coimbatore.The event was attended by over 150 senior pathologists, biochemists and laboratory technologists from reputed institutes. Erba’s global product manager, based at UK, Dr.Dimitris Giantzoudisand Dr. Avi Nahar, Head of Hematology, at Transasia, introduced the instruments to Doctors and provided scientific insights.
Dr. Muthusami,Chief Biochemist & Head of Quality, KMCH Coimbatore launched H 360, Dr. Prasanna Kumar, Professor for Academic Excellence at PSG Hospital launched H 560 and Dr. K. Subramaniam, Head of Clinical & Hematopathology at GKNM Hospital launched Elite 580.
Transasia also recognized senior pathologists (Dr. B. Asokan, Dean of Coimbatore Medical College and Hospital,Dr. K. Kadirvelu, Joint Director DRDO – BU, Dr. Isaac Christian Moses, Medical Director of Sri Ramakrishna Hospital, Dr. Raghu, senior Hematologist, and Dr. JansiRamalingam, nephro-pathologist and Head of Laboratories at Coimbatore Kidney Centre and Specialty Hospital) them with the title of ‘Lifetime Contribution to Lab Medicine.’ P. Meghanadan, Divisional Business Head- South Zone, proposed the vote of thanks.